Fundz Deep Dive
Everything you need to win Roche — in one platform.
Who to reach, what to say, and why now on Roche — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Roche — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Contract Type
partnership
GrindelwaldOtherBiotechnologyDescription
Roche has entered into a partnership with Danish company Zealand Pharma to expand its portfolio for the treatment of obesity and overweight. The exclusive license agreement will focus on further development and marketing of Petrelintide for obesity treatment.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months